Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: FEVER 40.5 TO 42 DEGREES CELSIUS; FEELING UNWELL; JOINT PAIN; COLD CHILLS; MUSCLE PAIN; FATIGUE; HEADACHE; This spontaneous report received from a consumer via a Regulatory Authority (EMEA EVHUMAN NLP, NL-LRB-00564155) concerned a 53 year old female. The patient''s weight was 59 kilograms, and height was 172 centimeters. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration and batch number were not reported) frequency one total, dose was not reported, administered on 01-JUN-2021 for covid-19 immunisation. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 01-JUN-2021, the patient experienced fever 40.5 to 42 degrees celsius, feeling unwell, joint pain, cold chills, muscle pain, fatigue and headache. On 02-JUN-2021, Laboratory data included: Hyperpyrexia (NR: not provided) Fever: 40.5 to 42 degrees celsius. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever 40.5 to 42 degrees celsius, headache, joint pain, fatigue, cold chills, muscle pain, and feeling unwell. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: 20210617421-covid-19 vaccine ad26.cov2. s-fever 40.5 to 42 degrees celsius. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166